Related references
Note: Only part of the references are listed.Role of the orexin (hypocretin) system in contextual fear conditioning in rats
Huiying Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Evaluation of Low versus High Volume per Minute Displacement CO2 Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology
Debra L. Hickman et al.
ANIMALS (2016)
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter et al.
SCIENTIFIC REPORTS (2016)
Recent trends in orexin research-2010 to 2015
Christoph Boss et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Both Ox1R and Ox2R orexin receptors contribute to the cardiorespiratory response evoked from the perifornical hypothalamus
Mirza I. Beig et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2-INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L. Johnson et al.
DEPRESSION AND ANXIETY (2015)
Both Ox1r and Ox2r orexin receptors contribute to the cardiovascular and locomotor components of the novelty stress response in the rat
Mirza I. Beig et al.
NEUROPHARMACOLOGY (2015)
Orexins and fear: implications for the treatment of anxiety disorders
Africa Flores et al.
TRENDS IN NEUROSCIENCES (2015)
Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses
Patricia Bonnavion et al.
NATURE COMMUNICATIONS (2015)
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
Africa Flores et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior
W. Heydendael et al.
PHYSIOLOGY & BEHAVIOR (2014)
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
Christine Dugovic et al.
FRONTIERS IN NEUROSCIENCE (2014)
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh et al.
FRONTIERS IN NEUROSCIENCE (2014)
Discovery and Characterization of ACT-335827, an Orally Available, Brain Penetrant Orexin Receptor Type1 Selective Antagonist
Michel A. Steiner et al.
CHEMMEDCHEM (2013)
Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats
Philip L. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine
Alessandro Gozzi et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
Robert M. Sears et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment
S. Ravinder et al.
TRANSLATIONAL PSYCHIATRY (2013)
Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
Philip L. Johnson et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
Philip L. Johnson et al.
PHYSIOLOGY & BEHAVIOR (2012)
An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus
Philip L. Johnson et al.
PHYSIOLOGY & BEHAVIOR (2012)
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Michel A. Steiner et al.
PSYCHOPHARMACOLOGY (2012)
The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
Geraldine M. Mang et al.
SLEEP (2012)
Orexin, stress, and anxiety/panic states
Philip L. Johnson et al.
OREXIN/HYPOCRETIN SYSTEM (2012)
A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses
Anantha Shekhar et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Mapping of microstimulation evoked responses and unit activity patterns in the lateral hypothalamic area recorded in awake humans Technical note
W. Bryan Wilent et al.
JOURNAL OF NEUROSURGERY (2011)
Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure
Philip L. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Induction of panic attack by stimulation of the ventromedial hypothalamus
W. Bryan Wilent et al.
JOURNAL OF NEUROSURGERY (2010)
A key role for orexin in panic anxiety
Philip L. Johnson et al.
NATURE MEDICINE (2010)
The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle
Mirela Barros Dias et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2010)
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2 receptor
P. Malherbe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Current use of benzodiazepines in anxiety disorders
Jean-Marc Clocis et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Hypocretin /orexin contributes to the expression of some but not all forms of stress and arousal
Teri M. Furlong et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
Christine Dugovic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Emotional and state-dependent modification of cardiorespiratory function: Role of orexinergic neurons
Tomoyuki Kuwaki et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Neural pathways underlying lactate-induced panic
Philip L. Johnson et al.
NEUROPSYCHOPHARMACOLOGY (2008)
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder
Mark Pollack et al.
PSYCHOPHARMACOLOGY (2007)
Control of hypothalamic orexin neurons by acid and CO2
Rhiannan H. Williams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hypocretin (orexin) cell loss in Parkinson's disease
Thomas C. Thannickal et al.
BRAIN (2007)
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder
Mark H. Pollack et al.
DEPRESSION AND ANXIETY (2007)
Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus
Anantha Shekhar et al.
JOURNAL OF NEUROSCIENCE (2006)
Deep brain stimulation in the posterior hypothalamus for chronic cluster headache. Case report and review of the literature
D. Rasche et al.
SCHMERZ (2006)
Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors
Philip L. Johnson et al.
JOURNAL OF NEUROSCIENCE (2006)
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
DS Baldwin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats
PL Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior
M Suzuki et al.
BRAIN RESEARCH (2005)
The diurnal rhythm of hypocretin in young and old F344 rats
F Desarnaud et al.
SLEEP (2004)
Characterisation of the binding of [H-3]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor
CJ Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Generalized anxiety disorder: comorbidity, comparative biology and treatment
DJ Nutt et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
E Mignot et al.
ARCHIVES OF NEUROLOGY (2002)
Tachycardia evoked by disinhibition of the dorsomedial hypothalamus in rats is mediated through medullary raphe
BC Samuels et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Orexins (hypocretins) directly excite tuberomammillary neurons
L Bayer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Arousal effect of orexin A depends on activation of hte histmic system
ZL Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Early coadministration of clonazepam with sertraline for panic disorder
AW Goddard et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Differential expression of orexin receptors 1 and 2 in the rat brain
JN Marcus et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
Evoking analogue subtypes of panic attacks in a nonclinical population using carbon dioxide-enriched air
JP Forsyth et al.
BEHAVIOUR RESEARCH AND THERAPY (2000)
Share Paper
